$953 Million is the total value of QVT Financial LP's 53 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 77.8% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
XBI | Buy | SPDR SERIES TRUSTput | $174,065,000 | +37.2% | 1,984,100 | +32.7% | 18.26% | +155.0% |
XBI | Buy | SPDR SERIES TRUSTs&p biotech | $66,417,000 | +131.8% | 757,067 | +124.3% | 6.97% | +330.8% |
Buy | INTEL CORPsdcv 3.250% 8/0 | $43,354,000 | +570.0% | 17,190,000 | +493.8% | 4.55% | +1145.8% | |
KANG | Buy | IKANG HEALTHCARE GROUP INCsponsored adr | $22,972,000 | +52.8% | 1,151,464 | +21.0% | 2.41% | +184.1% |
IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $22,534,000 | +161.6% | 1,411,695 | +25.6% | 2.36% | +386.2% |
GNRT | Buy | GENER8 MARITIME INC | $19,559,000 | +347.1% | 3,637,189 | +450.3% | 2.05% | +730.4% |
GDS | New | GDS HLDGS LTDsponsored adr | $14,924,000 | – | 573,736 | +100.0% | 1.56% | – |
FTSI | New | FTS INTERNATIONAL INC | $14,793,000 | – | 804,386 | +100.0% | 1.55% | – |
FB | New | FACEBOOK INCcl a | $9,763,000 | – | 61,100 | +100.0% | 1.02% | – |
TRCO | Buy | TRIBUNE MEDIA COcl a | $9,544,000 | +197.5% | 235,600 | +211.9% | 1.00% | +453.0% |
FRAC | Buy | KEANE GROUP INC | $7,085,000 | +9.6% | 478,695 | +40.8% | 0.74% | +103.6% |
PTEN | Buy | PATTERSON UTI ENERGY INC | $5,269,000 | -21.3% | 300,933 | +3.4% | 0.55% | +46.3% |
TTWO | New | TAKE-TWO INTERACTIVE SOFTWAR | $4,140,000 | – | 42,344 | +100.0% | 0.43% | – |
LBRT | New | LIBERTY OILFIELD SVCS INC | $4,065,000 | – | 240,700 | +100.0% | 0.43% | – |
GNK | New | GENCO SHIPPING & TRADING LTD | $1,919,000 | – | 134,935 | +100.0% | 0.20% | – |
EGLE | New | EAGLE BULK SHIPPING INC | $1,127,000 | – | 227,746 | +100.0% | 0.12% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MAKEMYTRIP LIMITED MAURITIUS | 38 | Q3 2023 | 6.2% |
NEW YORK TIMES CO | 34 | Q3 2023 | 2.6% |
ACCELERON PHARMA INC | 32 | Q3 2021 | 2.8% |
JPMORGAN CHASE & CO | 32 | Q3 2021 | 2.2% |
SAREPTA THERAPEUTICS INC | 32 | Q3 2023 | 1.1% |
BIOMARIN PHARMACEUTICAL INC | 32 | Q3 2023 | 0.5% |
GOLDMAN SACHS GROUP INC | 30 | Q3 2023 | 5.4% |
ACADIA PHARMACEUTICALS INC | 28 | Q3 2023 | 0.2% |
WELLS FARGO CO NEW | 27 | Q4 2020 | 1.5% |
NEXSTAR MEDIA GROUP INC | 26 | Q3 2023 | 3.4% |
View QVT Financial LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
MP Materials Corp. / DE | May 18, 2023 | 8,853,712 | 5.0% |
Grindrod Shipping Holdings Ltd.Sold out | February 14, 2022 | 0 | 0.0% |
AEHR TEST SYSTEMSSold out | February 14, 2020 | 0 | 0.0% |
Arbutus Biopharma CorpSold out | July 12, 2019 | 0 | 0.0% |
Axovant Gene Therapies Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
Myovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
Urovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
Axovant Sciences Ltd. | March 19, 2019 | 105,952,381 | 58.2% |
Hunter Maritime Acquisition Corp.Sold out | February 14, 2019 | 0 | 0.0% |
AGENUS INC | February 14, 2018 | 3,201,263 | 3.2% |
View QVT Financial LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
4 | 2024-03-07 |
SC 13G/A | 2024-03-07 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
4 | 2023-10-02 |
144 | 2023-09-28 |
13F-HR | 2023-08-14 |
SC 13D/A | 2023-05-18 |
View QVT Financial LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.